
Allergan Aesthetics Launches 2 Products For Acne-Prone Skin
Mona Gohara, MD, explained the importance of the products' impact on the skin barrier.
Allergan Aesthetics, under AbbVie's umbrella, unveiled 2 products today through its
Clinical studies affirmed the efficacy and tolerability of the SkinMedica Acne Clarifying Treatment and Pore Purifying Gel Cleanser, highlighting their ability to deliver clearer skin without compromising the skin barrier—a crucial aspect in acne management. This approach aligns with dermatologists' goals of treating acne effectively while preserving skin health. Mona Gohara, MD, board-certified dermatologist and associate clinical professor at Yale University in New Haven, Connecticut, underscored the significance of balancing acne treatment with skin barrier protection, citing SkinMedica's products as exemplary in achieving this equilibrium. She said in a press release, "Navigating the challenges posed by acne can be difficult, and most acne products are effective at targeting acne but ignore the impact of the ingredients on the skin barrier. My patients often find themselves in a bind when choosing acne products that treat acne but don't compromise the skin barrier. I am excited to offer my patients these new products from SkinMedica, which focus on sebum regulation and barrier protection to create a desirable balance of low irritation with strong efficacy.”
The SkinMedica Acne Clarifying Treatment integrates a formulation featuring 2% encapsulated salicylic acid, providing proactive defense against breakouts while addressing post-inflammatory hyperpigmentation and pore refinement. Complementing this, the SkinMedica Pore Purifying Cleanser combines salicylic acid with antioxidants and soothing botanicals to effectively cleanse and refresh the skin without causing undue irritation. The company wrote, “The product also includes ingredients like niacinamide and bakuchiol, which work together to reduce the appearance of discoloration and post-acne marks while refining pores and enhancing skin tone. With each application, this treatment becomes a shield, preserving the skin’s natural barrier.”
Jasson Gilmore, senior vice president of US Aesthetics said, “Acne is the most common skin concern in the US.2 It is also the primary reason patients schedule an office visit with their provider. For 25 years, SkinMedica has been dedicated to perfecting scientifically proven skincare that yields visible results. The formulations of the new products continue the legacy of promoting skin health and addressing key patient concerns like acne.” To better understand the product line, @SkinMedica posts on
Be sure to keep up with the latest Dermatology Times acne news. Here are some recent headlines.
Over 50% of women in their 20s and over 35% of women aged 30 to 39 years struggle with adult female cystic acne.
The statement said the petition came as a surprise to many ahead of AAD, and delves into the data complexity and patient considerations.
The 208SkinDoc dives into the efficacy and adverse effects of generic vitamin A to treat acne.
A newly published research letter in Environmental Health Perspectives further examined the testing methods used to detect benzene recently found in benzoyl peroxide (BPO)-containing acne products.
Recent trends show adolescents are using antiaging products, having Sephora shopping extravaganzas, and spending $500 to $1000 a month on skin care products that they don’t need. Unfortunately, this leads many of them to the dermatology office to help fix what the products caused: a compromised barrier, acne flares, skin irritation, and rashes.
References
1. SkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to Acne. News Release. Abbvie. April 9, 2024. Accessed April 9, 2024.
2. Acne: Overview. American Academy of Dermatology. Accessed April 9, 2024.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















